<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Sci Monit</journal-id><journal-id journal-id-type="iso-abbrev">Med. Sci. Monit</journal-id><journal-id journal-id-type="publisher-id">Medical Science Monitor</journal-id><journal-title-group><journal-title>Medical Science Monitor : International Medical Journal of Experimental and Clinical Research</journal-title></journal-title-group><issn pub-type="ppub">1234-1010</issn><issn pub-type="epub">1643-3750</issn><publisher><publisher-name>International Scientific Literature, Inc.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26205524</article-id><article-id pub-id-type="pmc">4517922</article-id><article-id pub-id-type="doi">10.12659/MSM.893677</article-id><article-id pub-id-type="publisher-id">893677</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research</subject></subj-group></article-categories><title-group><article-title>Comparison of Arthrodesis with Total Contact Casting for Midfoot Ulcerations Associated with Charcot Neuroarthropathy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="af1-medscimonit-21-2141">1</xref><xref ref-type="author-notes" rid="fn1-medscimonit-21-2141">A</xref><xref ref-type="author-notes" rid="fn2-medscimonit-21-2141">B</xref><xref ref-type="author-notes" rid="fn3-medscimonit-21-2141">C</xref><xref ref-type="author-notes" rid="fn4-medscimonit-21-2141">D</xref><xref ref-type="author-notes" rid="fn5-medscimonit-21-2141">E</xref><xref ref-type="author-notes" rid="fn6-medscimonit-21-2141">F</xref><xref ref-type="author-notes" rid="fn7-medscimonit-21-2141">G</xref><xref ref-type="corresp" rid="c1-medscimonit-21-2141"/></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Junlin</given-names></name><xref ref-type="aff" rid="af1-medscimonit-21-2141">1</xref><xref ref-type="author-notes" rid="fn1-medscimonit-21-2141">A</xref><xref ref-type="author-notes" rid="fn2-medscimonit-21-2141">B</xref><xref ref-type="author-notes" rid="fn3-medscimonit-21-2141">C</xref></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Fen</given-names></name><xref ref-type="aff" rid="af2-medscimonit-21-2141">2</xref><xref ref-type="author-notes" rid="fn2-medscimonit-21-2141">B</xref><xref ref-type="author-notes" rid="fn3-medscimonit-21-2141">C</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Gong</given-names></name><xref ref-type="aff" rid="af2-medscimonit-21-2141">2</xref><xref ref-type="author-notes" rid="fn3-medscimonit-21-2141">C</xref><xref ref-type="author-notes" rid="fn4-medscimonit-21-2141">D</xref></contrib><contrib contrib-type="author"><name><surname>Duan</surname><given-names>Xiaofen</given-names></name><xref ref-type="aff" rid="af2-medscimonit-21-2141">2</xref><xref ref-type="author-notes" rid="fn2-medscimonit-21-2141">B</xref></contrib><contrib contrib-type="author"><name><surname>Pan</surname><given-names>Heng</given-names></name><xref ref-type="aff" rid="af2-medscimonit-21-2141">2</xref><xref ref-type="author-notes" rid="fn2-medscimonit-21-2141">B</xref><xref ref-type="author-notes" rid="fn6-medscimonit-21-2141">F</xref></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Jiao</given-names></name><xref ref-type="aff" rid="af2-medscimonit-21-2141">2</xref><xref ref-type="author-notes" rid="fn4-medscimonit-21-2141">D</xref><xref ref-type="author-notes" rid="fn5-medscimonit-21-2141">E</xref></contrib></contrib-group><aff id="af1-medscimonit-21-2141"><label>1</label>Beijing Chao-Yang Hospital, Capital Medical University, Beijing, P.R. China</aff><aff id="af2-medscimonit-21-2141"><label>2</label>Beijing Feng-Tai Hospital, Capital Medical University, Beijing, P.R. China</aff><author-notes><corresp id="c1-medscimonit-21-2141">Corresponding Authors: Yan Wang, e-mail: <email>Jeryqq@sina.com</email>; Junlin Zhou, e-mail: <email>junlinzhou@yahoo.con</email></corresp><fn id="fn1-medscimonit-21-2141"><label>A</label><p>Study Design</p></fn><fn id="fn2-medscimonit-21-2141"><label>B</label><p>Data Collection</p></fn><fn id="fn3-medscimonit-21-2141"><label>C</label><p>Statistical Analysis</p></fn><fn id="fn4-medscimonit-21-2141"><label>D</label><p>Data Interpretation</p></fn><fn id="fn5-medscimonit-21-2141"><label>E</label><p>Manuscript Preparation</p></fn><fn id="fn6-medscimonit-21-2141"><label>F</label><p>Literature Search</p></fn><fn id="fn7-medscimonit-21-2141"><label>G</label><p>Funds Collection</p></fn></author-notes><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>24</day><month>7</month><year>2015</year></pub-date><volume>21</volume><fpage>2141</fpage><lpage>2148</lpage><history><date date-type="received"><day>26</day><month>1</month><year>2015</year></date><date date-type="accepted"><day>17</day><month>4</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; Med Sci Monit, 2015</copyright-statement><copyright-year>2015</copyright-year><license><license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</license-p></license></permissions><abstract><sec><title>Background</title><p>Gross deformity of the foot in Charcot neuroarthropathy can lead to foot collapse and subsequent ulceration, infection, amputation, or premature death. Total-contact casting (TCC) is a well-established treatment for neuropathic diabetic plantar foot ulcers. It was hypothesized that arthrodesis plus TCC may have advantages over TCC alone. This pilot study compared the effectiveness of arthrodesis plus TCC with TCC alone for the prevention, treatment, and recurrence of midfoot ulcerations associated with Charcot neuroarthropathy.</p></sec><sec><title>Material/Methods</title><p>Twenty-one subjects with plantar ulcers associated with unilateral diabetic Charcot midfoot neuroarthropathy were randomly assigned to ADS or TCC groups. The ADS group underwent an extended medial column arthrodesis procedure and TCC; ulcers were sutured directly. The TCC group underwent TCC alone with dressing changes. All patients underwent nerve conduction studies and quantitative sensory testing at baseline and during follow-up (6 and 12 months). Healing time and ulcer relapse rate were evaluated.</p></sec><sec><title>Result</title><p>Compared with the TCC group, there were fewer lesions in the ADS group after treatment (P&#x0003c;0.05). Temperature testing and vibration perception threshold improved significantly after ADS (P&#x0003c;0.05). Although the number of patients positive for pinprick and light touch sensations increased after surgery, not all patients recovered these sensations. Healing time was not significantly different between the 2 groups (24.25&#x000b1;3.89 <italic>vs.</italic> 25.89&#x000b1;2.84 days, P&#x0003e;0.05). There was no ulcer recurrence after 12 months in the ADS group compared with 33.3% in the TCC group.</p></sec><sec><title>Conclusions</title><p>An extended medial column arthrodesis may partly improve sensory impairments and restore protective sensation in patients with Charcot neuroarthropathy.</p></sec></abstract><kwd-group><title>MeSH Keywords</title><kwd>Arthrodesis</kwd><kwd>Diabetic Foot</kwd><kwd>Peripheral Nervous System Diseases</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Charcot neuroarthropathy (CNA) is a debilitating condition typically affecting diabetic patients with peripheral neuropathy. This condition will develop in 1 per 600 diabetic patients and in 1 per 100 diabetic patients with neuropathy [<xref rid="b1-medscimonit-21-2141" ref-type="bibr">1</xref>]. Severe foot and ankle deformity, recalcitrant ulcerations, and subsequent amputations usually result from untreated CNA [<xref rid="b1-medscimonit-21-2141" ref-type="bibr">1</xref>].</p><p>CNA in diabetic patients is usually unilateral [<xref rid="b2-medscimonit-21-2141" ref-type="bibr">2</xref>]. CNA lesions may affect the midfoot (60% of cases), forefoot (30%) or hindfoot and ankle (10%). Jeffcoate et al. [<xref rid="b3-medscimonit-21-2141" ref-type="bibr">3</xref>] suggested that causal factors were sensory neuropathy, adequate arterial circulation, and an inflammatory response. With these factors in place, any event exacerbating an inflammation cascade characterized by hypervascularity, cytokine activity, osteoclasis and disruption of osseous and soft tissue elements will lead to typical CNA lesions. Eventually, weight bearing will cause architectural disruption of the foot [<xref rid="b4-medscimonit-21-2141" ref-type="bibr">4</xref>]. Subsequent deformities of the foot, altered patterns of weight bearing and stress concentration then lead to ulcerations, recurrences, soft tissue and bony infections, amputations, and early mortality.</p><p>Although CNA is a well established complication of diabetes mellitus recognized by specialists, it is not easily diagnosed by non-specialists, particularly in its early stages [<xref rid="b1-medscimonit-21-2141" ref-type="bibr">1</xref>]. Patients often see a doctor because of a refractory ulcer or recurrent ulceration in the plantar area. Unfortunately, by that stage, the patients already have gross bone deformities.</p><p>Since neuropathic diabetic plantar foot ulcers are often found over a bony prominence, offloading to reduce pressure plays an important role in treatment. Total contact casting (TCC) is a method of offloading that is superior to a removable walking cast [<xref rid="b5-medscimonit-21-2141" ref-type="bibr">5</xref>,<xref rid="b6-medscimonit-21-2141" ref-type="bibr">6</xref>]. Alternative approaches to improving healing time, when a total-contact cast is unavailable or contraindicated, include placing the patient in a wedge-type shoe or walking boot, the use of flexible and rigid casting tape or felt aperture padding, or complete bed rest [<xref rid="b6-medscimonit-21-2141" ref-type="bibr">6</xref>&#x02013;<xref rid="b10-medscimonit-21-2141" ref-type="bibr">10</xref>]. Nonetheless, despite the availability of these various alternatives, TCC remains the &#x02018;gold standard&#x02019; treatment option [<xref rid="b6-medscimonit-21-2141" ref-type="bibr">6</xref>]. Although in most cases the use of a total-contact cast can be effective for allowing a patient to walk without undergoing surgery [<xref rid="b11-medscimonit-21-2141" ref-type="bibr">11</xref>,<xref rid="b12-medscimonit-21-2141" ref-type="bibr">12</xref>], there are drawbacks to this conservative method of treatment. Indeed, treatment with a total-contact cast limits the ability of a patient to function on a day-to-day basis for an extended period of time.</p><p>Arthrodesis has been described as an effective method of limb salvage for patients with CNA who have severe deformity and instability, and for who a cast or brace is not a treatment option and amputation seems inevitable. Current therapeutic efforts for chronic CNA are directed at supporting the foot architecture while the self-limited inflammatory response subsides and bone is reconstituted. Retrospective reports and prospective series of midfoot arthrodesis in CNA have shown that this technique is usually reserved for chronic cases with irreversible deformities and/or joint instability [<xref rid="b13-medscimonit-21-2141" ref-type="bibr">13</xref>] to improve foot plantar pressures and balance [<xref rid="b14-medscimonit-21-2141" ref-type="bibr">14</xref>,<xref rid="b15-medscimonit-21-2141" ref-type="bibr">15</xref>] and to minimize ulceration and foot amputation risk [<xref rid="b16-medscimonit-21-2141" ref-type="bibr">16</xref>].</p><p>No previous studies have directly compared arthrodesis and TCC with TCC alone. In view of the utility of arthrodesis in patients with severe deformity and instability, it was hypothesized that the additional use of arthrodesis in patients that would normally be treated with TCC alone may be therapeutically beneficial in the management of chronic midfoot ulceration and the prevention of its recurrence. Therefore, the present study was performed to compare the effectiveness of arthrodesis and TCC with TCC alone for the prevention (sensory nerve function and plantar pressure), treatment and recurrence of CNA midfoot ulcerations.</p></sec><sec sec-type="materials|methods"><title>Material and Methods</title><sec sec-type="subjects"><title>Patients</title><p>This was a pilot randomized prospective trial in 21 subjects (21 feet in 13 men and 8 women, average age of 64&#x000b1;9 years) conducted between August 2011 and December 2013. All patients were treated at the department of Orthopedic Surgery of the Beijing Feng Tai Hospital (China). The inclusion and exclusion criteria are presented in <xref ref-type="table" rid="t1-medscimonit-21-2141">Table 1</xref>. This study was approved by the medical ethics committee of the hospital and all patients provided written informed consent.</p></sec><sec sec-type="methods"><title>Study design</title><p>Subjects were assigned to the arthrodesis (ADS) or TCC groups using computer-generated random tables. The ADS group underwent an extended medial column arthrodesis procedure and TCC. The TCC group underwent TCC alone.</p></sec><sec><title>Arthrodesis</title><p>After induction of continuous epidural anesthesia and application of a thigh tourniquet, a curvilinear incision was made medial to the extensor hallucis longus and was made sufficiently long to expose the medial side of the foot for insertion of a plate and screws. The medial venous plexus was preserved as much as possible proximally and distally for post-operative edema management. The medial plantar nerve was identified within the incision and its thickness, position and blood supply were examined (<xref ref-type="fig" rid="f1-medscimonit-21-2141">Figure 1A, 1B</xref>). The lesion area was examined. Ligaments, articular cartilage, loose callus and fibrous tissue were excised to provide a good bed for arthrodesis. Dorsal soft tissue mobilization was minimal, but it was necessary to facilitate exostectomy, ostectomy and realignment. A linear medial capsulotomy was performed based on the apex of the Charcot deformity and often extended from the talonavicular joint to the first tarsometatarsal joint. A linear tenotomy of the tibialis anterior tendon was sometimes performed to facilitate necessary exposure and access to the entire medial column. The dorsal and plantar tendon stumps were tagged for re-approximation on closure.</p><p>Resection of the articular surfaces of the unstable segments of the medial column was achieved using an osteotome, curettage and/or sagittal saw osteotomies when necessary. Ostectomy was performed if necessary to facilitate improved sagittal and transverse plane alignment of the medial column. Using standard AO techniques, titanium screws and plates or screws alone were inserted from the medial and dorsal directions to ensure that a stable reduction was maintained and that compression was present across as many arthrodesis sites as possible. The size and placement of the plate and screws depended on the nature of the involved areas of the midfoot, the severity of the subluxations or dislocations, and the amount of bone fragmentation (<xref ref-type="fig" rid="f1-medscimonit-21-2141">Figure 1C, 1D</xref>). Prophylactic antibiotics were administered intravenously before the procedure and during the first 24 hours. After surgery, all patients were kept non-weight bearing in a cast for 6 to 12 weeks. Weight bearing was increased on the basis of radiographic and clinical assessment of union.</p></sec><sec><title>Total contact casting</title><p>With the patient lying prone, the leg was supported vertically with the knee flexed at 90&#x000b0; and the foot and ankle in neutral position. A roll of cotton cast (4- or 6-inch) (Webril, Kendall, Mansfield, MA, USA) was used to wrap the leg from the tibial tubercle to the forefoot. The cast roll was advanced by overlapping the previous layer by 50%, resulting in a thin layer of no more than 2 plies of cast. The plaster was carefully molded on the midfoot, hindfoot, heel, malleoli and tibial crest. During wrapping, the area of the lesion was exposed carefully. All patients were kept non-weight bearing until the plantar ulcer healed.</p></sec><sec><title>Treatment for the plantar ulcer</title><p>In the ADS group, debridement was performed before surgery and all ulcers were closed by direct suture after arthrodesis. In the TCC group, preparation of the ulcer for application of the cast included debridement of all necrotic tissues from the wound and paring of all calluses. The wound was covered with a sterile non-adherent dressing (Telfa, Kendall, Mansfield, MA, USA) before molding the cast. Dressings were changed once every 2 days through a window in the TCC until wound healing.</p></sec><sec sec-type="methods"><title>Data collection</title><p>All nerve studies were conducted at baseline (2 weeks before surgery), 6 months after surgery and 12 months after surgery. Follow-up ended at 12 months for the present study. All nerve conduction studies (NCS) and quantitative sensory testing (QST) were performed by the same physician who was blinded to the study grouping.</p></sec><sec><title>Nerve conduction studies</title><p>Standardized techniques for NCS with controlled temperature (skin at 30&#x000b0;C and room at 25&#x000b0;C), quiet environment and fixed distal distances were used. Temperature equilibrium between body and environment was achieved using a 20-minute rest. The peroneal, tibial and sural nerves on the side affected by CNA were tested. Sensory NCS were performed antidromically. All stimulations and recordings were done using surface electrodes. Corresponding distances for sensory NCS were 130 mm for the peroneal nerve, 110 mm for the tibial nerve, and 140 mm for the sural nerve. Measurements of distances, response latencies and amplitudes were done in a standard fashion using onset latencies and baseline-to-peak amplitudes. Measurements from the initial positive peak to negative peak were made for sensory responses.</p></sec><sec><title>Quantitative sensory testing</title><p>QST was based on 4 parameters. Testing was performed in a quiet indoor environment with a room temperature of 25&#x000b0;C and skin temperature of 30&#x000b0;C. Vibration perception threshold (VPT) was assessed using a 128-Hz Rydel-Seiffer tuning fork [<xref rid="b17-medscimonit-21-2141" ref-type="bibr">17</xref>] at the plantar hallux. Temperature sensation, including cold perception threshold (CPT) and warm perception threshold (WPT), was measured on the lateral dorsal foot at 32&#x000b0;C, a temperature range of 0&#x02013;50&#x000b0;C, and a temperature change rate of 1&#x000b0;C/s. Temperature sensation was measured 2 times at each point, with a time interval of 5 seconds. Pain sensation was investigated using a Pinprick test. Light touch was assessed using a 10-g Semmes-Weinstein monofilament (SWMF). The nylon filament was placed perpendicular to the plantar foot skin at 3 predetermined points. Pressure was applied until the filament buckled. The filament was held in place for approximately 1 second and then released.</p></sec><sec><title>Follow-up</title><p>All patients were followed up for 12 months. Orthopedic adverse reactions were assessed using physical examination and X-rays.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>Continuous data are presented as mean and standard deviation, and were analyzed using independent sample t-tests. A 2&#x000d7;3 (group&#x000d7;times testing) repeated-measures multiple analysis of variance (ANOVA) was used to determine differences for each of the lower peripheral nerve performance measures. P-values &#x0003c;0.05 were considered significantly different. Analysis was conducted using SPSS 18 (IBM, Armonk, NY, USA).</p></sec></sec><sec sec-type="results"><title>Results</title><sec sec-type="intro|subjects"><title>Characteristics of the patients</title><p><xref ref-type="table" rid="t2-medscimonit-21-2141">Table 2</xref> presents the characteristics of the patients. Most subjects were overweight or obese. All subjects had plantar numbness, and 10 of them had plantar pain, which was typically described as a burning sensation. The preoperative ankle-brachial index of all patients was normal. Glycemic control was poor. There was no difference between the 2 groups for demographics (<xref ref-type="table" rid="t2-medscimonit-21-2141">Table 2</xref>).</p></sec><sec><title>Ulcerations</title><p>There was no significant difference (all P&#x0003e;0.05) between the ADS and TCC groups in ulcer number, duration and dimension (<xref ref-type="table" rid="t3-medscimonit-21-2141">Table 3</xref>). All ulcers in the ADS and TCC groups healed after treatment (24.25&#x000b1;3.89 <italic>vs.</italic> 25.89&#x000b1;2.84 days, P=0.632). Re-ulceration rates were significantly higher in the TCC group compared with the ADS group. At one year of follow-up, 3 of the 9 (33.3%) patients in the TCC group suffered from new ulcers, compared with none in the ADS group (P&#x0003c;0.05).</p></sec><sec><title>Nerve conduction</title><p>NCS data are presented in <xref ref-type="table" rid="t4-medscimonit-21-2141">Table 4</xref>. All NCS parameters at baseline were comparable between the 2 groups (all P&#x0003e;0.05). Group&#x000d7;time interactions were observed for tibial nerve and peroneal nerve conduction, indicating that ADS affected these variables over time differently than TCC.</p><p>Mean tibial nerve amplitude and latency improved after arthrodesis (P&#x0003c;0.05 baseline <italic>vs.</italic> 6 months, <xref ref-type="table" rid="t4-medscimonit-21-2141">Table 4</xref>) and did not change further at 12 months. At 12 months, tibial nerve amplitude and latency following TCC were not improved (all P&#x0003e;0.05, <xref ref-type="table" rid="t4-medscimonit-21-2141">Table 4</xref>). At 12 months, tibial nerve conduction after ADS was not different from baseline (P&#x0003e;0.05), but was decreased in the TCC group (P&#x0003c;0.05).</p><p>Mean peroneal nerve amplitude and latency improved after arthrodesis (P&#x0003c;0.05 baseline <italic>vs.</italic> 6 months, <xref ref-type="table" rid="t4-medscimonit-21-2141">Table 4</xref>) and did not change further at 12 months. At 12 months, peroneal nerve amplitude and latency following TCC were decreased (P&#x0003c;0.05, <xref ref-type="table" rid="t4-medscimonit-21-2141">Table 4</xref>). At 12 months, peroneal nerve conduction after ADS was improved (P&#x0003c;0.05), but was unchanged in the TCC group (P&#x0003c;0.05).</p></sec><sec><title>Quantitative sensory testing</title><p>In the ADS group 6 months after surgery, QST scores including CPT, WBT and VBT improved significantly (P&#x0003c;0.05). Furthermore, at 12 months, VBT was improved compared with 6 months (P&#x0003c;0.05) (<xref ref-type="table" rid="t5-medscimonit-21-2141">Table 5</xref>). In the TCC group, CPT, WPT and VPT were not different between baseline and 12 months. Pinprick and light touch sensory testing improved in the ADS group after arthrodesis.</p></sec><sec><title>Adverse events</title><p>In the ADS group, one patient suffered from acute ankle joint arthropathy, which was managed using external fixation. No arch collapse was observed.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>The aim of the present study was to compare the effectiveness of arthrodesis plus TCC with TCC alone for the prevention, treatment and recurrence of midfoot ulcerations associated with CNA. The main finding was that although there were no differences in healing times between the 2 treatment approaches, the use of arthrodesis and TCC resulted in no ulcer recurrence at 12 months, compared with a recurrence rate of 33.3% for TCC alone. Tibial nerve function, peroneal nerve function, temperature sensation and vibration perception were all improved after arthrodesis plus TCC, but not after TCC alone. The number of patients who were positive for pinprick and light touch sensations also increased after surgery, but not all patients recovered these sensory perceptions. These data indicate that, compared with TCC alone, the combination of arthrodesis and TCC may reduce ulcer recurrence rate by improving the functions of the tibial and peroneal nerves and sensory perception in various modalities.</p><p>The midfoot is the most commonly affected area in CNA, but an atypical deformity associated with this condition is the rocker-bottom foot, which is caused by collapse of the longitudinal arch of the foot. This, along with instability of the ankle joint, is reportedly the major cause of morbidity in CNA [<xref rid="b18-medscimonit-21-2141" ref-type="bibr">18</xref>]. Joint instability resulting in repetitive nerve injury and abnormal prominent lesions of bone, which cause further stress to the nerve, both lead to a vicious cycle of neuropathy and further accelerate the development of the Charcot foot. As observed during surgery, the medial and lateral plantar nerves within the tarsal showed visible ischemia and thinning caused by bone compression (<xref ref-type="fig" rid="f1-medscimonit-21-2141">Figure 1</xref>).</p><p>Previous studies have suggested that the natural history of diabetic peripheral neuropathy (DPN) is progressive and irreversible, and that when DPN occurs in patients with a long duration of diabetes, the severity of nerve injury is more serious and it is more difficult to restore sensory and motor function [<xref rid="b19-medscimonit-21-2141" ref-type="bibr">19</xref>,<xref rid="b20-medscimonit-21-2141" ref-type="bibr">20</xref>]. However, this theory may not apply to unilateral Charcot foot, as evidenced by the results of the NCS and QST performed in the present study.</p><p>The NCS is regarded as an objective, quantitative, non-invasive and reliable test, and as the &#x0201c;gold standard&#x0201d; for evaluating peripheral neuropathy in thick myelinated nerve fibers. In the present study, the amplitudes and conduction velocities of the tibial and peroneal nerves in patients in the arthrodesis group were significantly improved 6 months after surgery, and the values at 12 months were similar to those at 6 months. Although the postoperative nerve conduction velocity values in the arthrodesis group remained significantly lower than normal values [<xref rid="b21-medscimonit-21-2141" ref-type="bibr">21</xref>], these results nonetheless suggest that arthrodesis is effective for nerve recovery. In contrast, there were no improvements in tibial and peroneal nerve function in patients treated with TCC alone. Thus, the combination of arthrodesis with TCC appears superior to TCC alone in facilitating a recovery in the function of thick myelinated nerve fibers.</p><p>However, NCS data reflect only the conduction of thick myelinated nerve fibers, and are not sensitive to lesions in small nerve fibers [<xref rid="b22-medscimonit-21-2141" ref-type="bibr">22</xref>]. Therefore, the present study also carried out QST, as this is sensitive to small nerve fibers, including sensory fibers mediating the perception of vibration, cold temperature and warm temperature. A previous study reported that vibration perception at the hallux was abnormal in subjects with CNA, and that this abnormality was asymmetric [<xref rid="b23-medscimonit-21-2141" ref-type="bibr">23</xref>]. A potential confounding variable is the possibility that a Charcot foot transmits vibration less efficiently than a normal foot and thus the difference could represent simple mechanical changes in bone structure or inflammatory changes around the joint [<xref rid="b24-medscimonit-21-2141" ref-type="bibr">24</xref>]; this is supported by the findings of the present study. In the arthrodesis group, vibratory sensation was improved 12 months post-surgery compared with 6 months post-surgery. In addition, CPT and WPT were also clearly improved in this group, compared with baseline. The number of patients who were positive for pinprick and light touch sensations also increased after arthrodesis, but not all the patients recovered these sensory perceptions. In contrast, the results of QST were not improved in the TCC group, mirroring the findings of the NCS. The reason for the lack of improvement in the TCC group may be that the anatomic structures had not been restored in these patients.</p><p>Although previous investigations have reported benefits of arthrodesis for the treatment of Charcot foot, the present study is the first to directly compare arthrodesis plus TCC with TCC alone for the management of midfoot ulcerations associated with Charcot neuroarthropathy. Consistent with this study, Simon et al. found that arthrodesis of the tarsal-metatarsal area followed by limb immobilization (in a non-weight-bearing cast) could improve function in patients with diabetes and Eichenholtz stage-I Charcot arthropathy, with none of the 14 patients reporting ulceration after surgery [<xref rid="b14-medscimonit-21-2141" ref-type="bibr">14</xref>]. A similar utility of arthrodesis followed by immobilization (in a weight-bearing cast) has been reported in patients with Charcot foot of various causes (including diabetes), and it has been argued that appropriate treatment of structural deformity of the foot by an orthopedic surgeon can reduce the incidence of permanent deformity, disability and ulceration [<xref rid="b25-medscimonit-21-2141" ref-type="bibr">25</xref>]. Thus, it is possible that more widespread use of arthrodesis in patients conventionally treated with TCC alone may improve overall outcomes.</p><p>In the case of an unstable, non-shoeable Charcot foot, it is the authors&#x02019; opinion that the most definitive long-term stability may be obtained using aggressive fusion techniques. Both the Lisfranc and midtarsal joints are susceptible to complex fracture dislocations due to CNA. In many instances, both joint segments are affected, requiring realignment and arthrodesis of the midfoot. The repair of the midtarsal joint is considerably more challenging to perform and is sometimes associated with a requirement for arthrodesis of the Lisfranc joint. In many cases, the navicular rests below the displaced medial cuneiform medially, and the cuboid is dislocated plantarly beneath the bases of the fourth and fifth metatarsals. On the lateral view, it is often possible to detect that the cuboid is plantarly dislocated beneath the metatarsal bases. An intractable ulceration often forms at the site of highest plantar pressure, lateral to the site of the plantarly dislocated cuboid. An ulcer such as this is unlikely to resolve with the use of bracing or special shoes, as evidenced by the findings in the present study: no ulcer recurrence was observed 12 months after arthrodesis, whereas a third of the patients in the TCC group suffered from recurrences. These data are supported by those of a previous study [<xref rid="b26-medscimonit-21-2141" ref-type="bibr">26</xref>]. It is likely that the lack of surgical repair in the TCC group led to high pressures at the base of the foot, which in turn predisposed to ulceration and subsequent infections [<xref rid="b27-medscimonit-21-2141" ref-type="bibr">27</xref>].</p><p>The present study suffers from some limitations. First, the number of patients was small. Second, these patients were from a single center and were all operated on by a single orthopedist. Larger multicenter clinical trials are necessary to draw firm conclusions about the management of Charcot foot.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>An extended medial column arthrodesis may partly improve sensory impairment and restore protective sensation in patients with Charcot neuroarthropathy.</p></sec></body><back><ack><title>Acknowledgements</title><p>The authors acknowledge the invaluable participation of the patients.</p></ack><fn-group><fn id="fn8-medscimonit-21-2141"><p><bold>Competing interests</bold></p><p>The authors have no competing interests to declare.</p></fn><fn id="fn9-medscimonit-21-2141"><p><bold>Source of support:</bold> Departmental sources</p></fn></fn-group><ref-list><title>References</title><ref id="b1-medscimonit-21-2141"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabrin</surname><given-names>J</given-names></name><name><surname>Larsen</surname><given-names>K</given-names></name><name><surname>Holstein</surname><given-names>PE</given-names></name></person-group><article-title>Long-term follow-up in diabetic Charcot feet with spontaneous onset</article-title><source>Diabetes Care</source><year>2000</year><volume>23</volume><fpage>796</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">10840999</pub-id></element-citation></ref><ref id="b2-medscimonit-21-2141"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>MJ</given-names></name><name><surname>Edmonds</surname><given-names>ME</given-names></name><name><surname>Foster</surname><given-names>AV</given-names></name><name><surname>Watkins</surname><given-names>PJ</given-names></name></person-group><article-title>Selective neuropathy and preserved vascular responses in the diabetic Charcot foot</article-title><source>Diabetologia</source><year>1992</year><volume>35</volume><fpage>148</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">1547919</pub-id></element-citation></ref><ref id="b3-medscimonit-21-2141"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffcoate</surname><given-names>WJ</given-names></name><name><surname>Chipchase</surname><given-names>SY</given-names></name><name><surname>Ince</surname><given-names>P</given-names></name><name><surname>Game</surname><given-names>FL</given-names></name></person-group><article-title>Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures</article-title><source>Diabetes Care</source><year>2006</year><volume>29</volume><fpage>1784</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">16873780</pub-id></element-citation></ref><ref id="b4-medscimonit-21-2141"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimmerle</surname><given-names>R</given-names></name><name><surname>Chantelau</surname><given-names>E</given-names></name></person-group><article-title>Weight-bearing intensity produces charcot deformity in injured neuropathic feet in diabetes</article-title><source>Exp Clin Endocrinol Diabetes</source><year>2007</year><volume>115</volume><fpage>360</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">17701880</pub-id></element-citation></ref><ref id="b5-medscimonit-21-2141"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashefsky</surname><given-names>H</given-names></name><name><surname>Marston</surname><given-names>W</given-names></name></person-group><article-title>Total contact casting combined with human fibroblast-derived dermal tissue in 15 DFU patients</article-title><source>J Wound Care</source><year>2012</year><volume>21</volume><issue>5</issue><fpage>236</fpage><fpage>8</fpage><fpage>40</fpage><fpage>42</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">22584742</pub-id></element-citation></ref><ref id="b6-medscimonit-21-2141"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>J</given-names></name><name><surname>Koshimune</surname><given-names>D</given-names></name><name><surname>Moellmer</surname><given-names>R</given-names></name></person-group><article-title>Foot ulcers &#x02013; treatment and prevention</article-title><source>Chapter 12 in Type 2 Diabetes</source><person-group person-group-type="editor"><name><surname>Masuo</surname><given-names>K</given-names></name></person-group><publisher-name>InTech</publisher-name><year>2013</year></element-citation></ref><ref id="b7-medscimonit-21-2141"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergin</surname><given-names>SM</given-names></name><name><surname>Gurr</surname><given-names>JM</given-names></name><name><surname>Allard</surname><given-names>BP</given-names></name><etal/></person-group><article-title>Australian Diabetes Foot Network: management of diabetes-related foot ulceration &#x02013; a clinical update</article-title><source>Med J Aust</source><year>2012</year><volume>197</volume><fpage>226</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">22900873</pub-id></element-citation></ref><ref id="b8-medscimonit-21-2141"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besse</surname><given-names>JL</given-names></name><name><surname>Leemrijse</surname><given-names>T</given-names></name><name><surname>Deleu</surname><given-names>PA</given-names></name></person-group><article-title>Diabetic foot: the orthopedic surgery angle</article-title><source>Orthop Traumatol Surg Res</source><year>2011</year><volume>97</volume><fpage>314</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">21493174</pub-id></element-citation></ref><ref id="b9-medscimonit-21-2141"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Leon</surname><given-names>JM</given-names></name><name><surname>Driver</surname><given-names>VR</given-names></name><name><surname>Fylling</surname><given-names>CP</given-names></name><etal/></person-group><article-title>The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel</article-title><source>Adv Skin Wound Care</source><year>2011</year><volume>24</volume><fpage>357</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">21768787</pub-id></element-citation></ref><ref id="b10-medscimonit-21-2141"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malone</surname><given-names>M</given-names></name><name><surname>Gannass</surname><given-names>AA</given-names></name><name><surname>Bowling</surname><given-names>F</given-names></name></person-group><article-title>Flexible and rigid casting tape as a novel approach to offloading diabetic foot ulcers</article-title><source>J Wound Care</source><year>2011</year><volume>20</volume><fpage>335</fpage><lpage>36</lpage><fpage>338</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">21841722</pub-id></element-citation></ref><ref id="b11-medscimonit-21-2141"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>DG</given-names></name><name><surname>Lavery</surname><given-names>LA</given-names></name><name><surname>Harkless</surname><given-names>LB</given-names></name></person-group><article-title>Treatment-based classification system for assessment and care of diabetic feet</article-title><source>J Am Podiatr Med Assoc</source><year>1996</year><volume>86</volume><fpage>311</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">8757481</pub-id></element-citation></ref><ref id="b12-medscimonit-21-2141"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sammarco</surname><given-names>GJ</given-names></name><name><surname>Conti</surname><given-names>SF</given-names></name></person-group><article-title>Surgical treatment of neuroarthropathic foot deformity</article-title><source>Foot Ankle Int</source><year>1998</year><volume>19</volume><fpage>102</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9498583</pub-id></element-citation></ref><ref id="b13-medscimonit-21-2141"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouveri</surname><given-names>E</given-names></name><name><surname>Papanas</surname><given-names>N</given-names></name></person-group><article-title>Charcot osteoarthropathy in diabetes: A brief review with an emphasis on clinical practice</article-title><source>World J Diabetes</source><year>2011</year><volume>2</volume><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">21691556</pub-id></element-citation></ref><ref id="b14-medscimonit-21-2141"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>SR</given-names></name><name><surname>Tejwani</surname><given-names>SG</given-names></name><name><surname>Wilson</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Arthrodesis as an early alternative to nonoperative management of charcot arthropathy of the diabetic foot</article-title><source>J Bone Joint Surg Am</source><year>2000</year><volume>82-A</volume><fpage>939</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">10901308</pub-id></element-citation></ref><ref id="b15-medscimonit-21-2141"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinacore</surname><given-names>DR</given-names></name><name><surname>Bohnert</surname><given-names>KL</given-names></name><name><surname>Hastings</surname><given-names>MK</given-names></name><name><surname>Johnson</surname><given-names>JE</given-names></name></person-group><article-title>Mid foot kinetics characterize structural polymorphism in diabetic foot disease</article-title><source>Clin Biomech (Bristol, Avon)</source><year>2008</year><volume>23</volume><fpage>653</fpage><lpage>61</lpage></element-citation></ref><ref id="b16-medscimonit-21-2141"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappalardo</surname><given-names>J</given-names></name><name><surname>Fitzgerald</surname><given-names>R</given-names></name></person-group><article-title>Utilization of advanced modalities in the management of diabetic Charcot neuroarthropathy</article-title><source>J Diabetes Sci Technol</source><year>2010</year><volume>4</volume><fpage>1114</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">20920430</pub-id></element-citation></ref><ref id="b17-medscimonit-21-2141"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bracewell</surname><given-names>N</given-names></name><name><surname>Game</surname><given-names>F</given-names></name><name><surname>Jeffcoate</surname><given-names>W</given-names></name><name><surname>Scammell</surname><given-names>BE</given-names></name></person-group><article-title>Clinical evaluation of a new device in the assessment of peripheral sensory neuropathy in diabetes</article-title><source>Diabet Med</source><year>2012</year><volume>29</volume><fpage>1553</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">22672257</pub-id></element-citation></ref><ref id="b18-medscimonit-21-2141"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frykberg</surname><given-names>RG</given-names></name><name><surname>Belczyk</surname><given-names>R</given-names></name></person-group><article-title>Epidemiology of the Charcot foot</article-title><source>Clin Podiatr Med Surg</source><year>2008</year><volume>25</volume><fpage>17</fpage><lpage>28</lpage><fpage>v</fpage><pub-id pub-id-type="pmid">18165108</pub-id></element-citation></ref><ref id="b19-medscimonit-21-2141"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callaghan</surname><given-names>BC</given-names></name><name><surname>Cheng</surname><given-names>HT</given-names></name><name><surname>Stables</surname><given-names>CL</given-names></name><etal/></person-group><article-title>Diabetic neuropathy: clinical manifestations and current treatments</article-title><source>Lancet Neurol</source><year>2012</year><volume>11</volume><fpage>521</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">22608666</pub-id></element-citation></ref><ref id="b20-medscimonit-21-2141"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesfaye</surname><given-names>S</given-names></name><name><surname>Selvarajah</surname><given-names>D</given-names></name></person-group><article-title>Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy</article-title><source>Diabetes Metab Res Rev</source><year>2012</year><volume>28</volume><issue>Suppl 1</issue><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">22271716</pub-id></element-citation></ref><ref id="b21-medscimonit-21-2141"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinnreich</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>BV</given-names></name><name><surname>Dyck</surname><given-names>PJ</given-names></name></person-group><article-title>Diabetic neuropathies. Classification, clinical features, and pathophysiological basis</article-title><source>Neurologist</source><year>2005</year><volume>11</volume><fpage>63</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">15733329</pub-id></element-citation></ref><ref id="b22-medscimonit-21-2141"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauplannaz</surname><given-names>G</given-names></name><name><surname>Vial</surname><given-names>C</given-names></name></person-group><trans-title xml:lang="en">Electrodiagnostic assessment of neuromuscular junction disorders</trans-title><source>Rev Med Liege</source><year>2004</year><volume>59</volume><issue>Suppl 1</issue><fpage>184</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">15244175</pub-id></element-citation></ref><ref id="b23-medscimonit-21-2141"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valabhji</surname><given-names>J</given-names></name><name><surname>Marshall</surname><given-names>RC</given-names></name><name><surname>Lyons</surname><given-names>S</given-names></name><etal/></person-group><article-title>Asymmetrical attenuation of vibration sensation in unilateral diabetic Charcot foot neuroarthropathy</article-title><source>Diabet Med</source><year>2012</year><volume>29</volume><fpage>1191</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">22276944</pub-id></element-citation></ref><ref id="b24-medscimonit-21-2141"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>YL</given-names></name><name><surname>Leoh</surname><given-names>TH</given-names></name><name><surname>Lim</surname><given-names>LL</given-names></name><etal/></person-group><article-title>The laterality index in the evaluation of distal sensorimotor neuropathy</article-title><source>J Clin Neuromuscul Dis</source><year>2008</year><volume>10</volume><fpage>18</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">18772696</pub-id></element-citation></ref><ref id="b25-medscimonit-21-2141"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>G</given-names></name></person-group><article-title>Arthrodesis and the total-contact cast in treatment of the neuropathic foot</article-title><source>J Bone Joint Surg Am</source><year>2001</year><volume>83-a</volume><fpage>1436</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">11568219</pub-id></element-citation></ref><ref id="b26-medscimonit-21-2141"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>MJ</given-names></name><name><surname>Minor</surname><given-names>SD</given-names></name><name><surname>Diamond</surname><given-names>JE</given-names></name><name><surname>Blair</surname><given-names>VP</given-names><suffix>III</suffix></name></person-group><article-title>Relationship of foot deformity to ulcer location in patients with diabetes mellitus</article-title><source>Phys Ther</source><year>1990</year><volume>70</volume><fpage>356</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">2345779</pub-id></element-citation></ref><ref id="b27-medscimonit-21-2141"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aszmann</surname><given-names>O</given-names></name><name><surname>Tassler</surname><given-names>PL</given-names></name><name><surname>Dellon</surname><given-names>AL</given-names></name></person-group><article-title>Changing the natural history of diabetic neuropathy: incidence of ulcer/amputation in the contralateral limb of patients with a unilateral nerve decompression procedure</article-title><source>Ann Plast Surg</source><year>2004</year><volume>53</volume><fpage>517</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">15602245</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-medscimonit-21-2141" position="float"><label>Figure 1</label><caption><p>A 64-year old man with a diabetic Charcot foot. (<bold>A</bold>) Yellowish change in color of the tibial nerve in the tarsal tunnel. (<bold>B</bold>) The apex of the deformity was the tarsometatarsal and naviculocuneiform joints. (<bold>C</bold>) The patient underwent reconstruction of the medial column using an anterior cervical plate and limited internal screw fixation. (<bold>D</bold>) Re-establishment of structural alignment and bone fusion 12 months after surgery.</p></caption><graphic xlink:href="medscimonit-21-2141-g001"/></fig><table-wrap id="t1-medscimonit-21-2141" position="float"><label>Table 1</label><caption><p>Inclusion and exclusion criteria.</p></caption><table frame="hsides" rules="rows"><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Inclusion criteria</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1. Unilateral medial column deformity (involving the talus, navicular, cuneiforms, or 1<sup>st</sup>, 2<sup>nd</sup> or 3<sup>rd</sup> metatarsal) based on the location of the Charcot neuroarthropathy</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2. Radiographic evidence of overt arthropathy</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">3. Limb-threatening ulceration associated with diabetic CNA</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4. Fixed, non-reducible midfoot deformity</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Exclusion criteria</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1. Osteomyelitis</td></tr></tbody></table></table-wrap><table-wrap id="t2-medscimonit-21-2141" position="float"><label>Table 2</label><caption><p>Patient characteristics.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="middle" align="center" rowspan="1" colspan="1">Variable</th><th valign="middle" align="center" rowspan="1" colspan="1">Arthrodesis (<italic>n</italic>=12)</th><th valign="middle" align="center" rowspan="1" colspan="1">Total contact cast (<italic>n</italic>=9)</th></tr></thead><tbody><tr><td valign="middle" align="left" rowspan="1" colspan="1">Age (years)</td><td valign="middle" align="center" rowspan="1" colspan="1">62.8&#x000b1;3.6</td><td valign="middle" align="center" rowspan="1" colspan="1">65.0&#x000b1;3.8</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Duration of diabetes (months)</td><td valign="middle" align="center" rowspan="1" colspan="1">15.3&#x000b1;4.5</td><td valign="middle" align="center" rowspan="1" colspan="1">15.9&#x000b1;4.0</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Males (females)</td><td valign="middle" align="center" rowspan="1" colspan="1">7 (5)</td><td valign="middle" align="center" rowspan="1" colspan="1">5 (4)</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td valign="middle" align="center" rowspan="1" colspan="1">33.4&#x000b1;4.9</td><td valign="middle" align="center" rowspan="1" colspan="1">30.4&#x000b1;5.6</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">HbA1c (%)</td><td valign="middle" align="center" rowspan="1" colspan="1">7.8&#x000b1;0.9</td><td valign="middle" align="center" rowspan="1" colspan="1">7.5&#x000b1;1.0</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Foot ulcers (<italic>n</italic>)</td><td valign="middle" align="center" rowspan="1" colspan="1">11</td><td valign="middle" align="center" rowspan="1" colspan="1">9</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Ulcers (cm<sup>2</sup>)</td><td valign="middle" align="center" rowspan="1" colspan="1">5.7&#x000b1;1.7</td><td valign="middle" align="center" rowspan="1" colspan="1">5.0&#x000b1;1.7</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-medscimonit-21-2141"><p>Results are presented as mean &#x000b1; standard deviation, or numbers. All variables were comparable between the two groups.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-medscimonit-21-2141" position="float"><label>Table 3</label><caption><p>Wound healing time according to treatment.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="middle" align="center" rowspan="1" colspan="1">Variable</th><th valign="middle" align="center" rowspan="1" colspan="1">Arthrodesis (<italic>n</italic>=12)</th><th valign="middle" align="center" rowspan="1" colspan="1">Total contact cast (<italic>n</italic>=9)</th></tr></thead><tbody><tr><td valign="middle" align="left" rowspan="1" colspan="1">Ulcer duration (days)</td><td valign="middle" align="center" rowspan="1" colspan="1">25.3&#x000b1;6.5</td><td valign="middle" align="center" rowspan="1" colspan="1">27.9&#x000b1;4.0</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Ulcers (cm<sup>2</sup>)</td><td valign="middle" align="center" rowspan="1" colspan="1">5.7&#x000b1;1.7</td><td valign="middle" align="center" rowspan="1" colspan="1">5.0&#x000b1;1.7</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Healing time (days)</td><td valign="middle" align="center" rowspan="1" colspan="1">24.3&#x000b1;3.9</td><td valign="middle" align="center" rowspan="1" colspan="1">25.9&#x000b1;2.8</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Recurrence rate</td><td valign="middle" align="center" rowspan="1" colspan="1">0%</td><td valign="middle" align="center" rowspan="1" colspan="1">33.3%<xref ref-type="table-fn" rid="tfn2-medscimonit-21-2141">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="tfn2-medscimonit-21-2141"><label>*</label><p>P&#x0003c;0.05 <italic>vs.</italic> the arthrodesis group.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-medscimonit-21-2141" position="float"><label>Table 4</label><caption><p>Nerve conduction velocity according to treatment.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="middle" align="center" rowspan="1" colspan="1">Variable</th><th valign="middle" align="center" rowspan="1" colspan="1">Group (total <italic>n</italic>)</th><th valign="middle" align="center" rowspan="1" colspan="1">Baseline (<italic>n</italic> of positive)</th><th valign="middle" align="center" rowspan="1" colspan="1">6 months (<italic>n</italic> of positive)</th><th valign="middle" align="center" rowspan="1" colspan="1">12 months (<italic>n</italic> of positive)</th><th valign="middle" align="center" rowspan="1" colspan="1">P-value for group-time interaction</th></tr></thead><tbody><tr><td valign="middle" rowspan="2" align="left" colspan="1">Tibia nerve amplitude (&#x003bc;V)</td><td valign="top" align="left" rowspan="1" colspan="1">Arthrodesis (12)</td><td valign="top" align="center" rowspan="1" colspan="1">0.85&#x000b1;0.21 (8)</td><td valign="top" align="center" rowspan="1" colspan="1">4.31&#x000b1;1.41<xref ref-type="table-fn" rid="tfn3-medscimonit-21-2141">*</xref> (12)<xref ref-type="table-fn" rid="tfn3-medscimonit-21-2141">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">5.71&#x000b1;1.29<xref ref-type="table-fn" rid="tfn3-medscimonit-21-2141">*</xref> (12)<xref ref-type="table-fn" rid="tfn3-medscimonit-21-2141">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total contact cast (9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.85&#x000b1;0.20 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">1.08&#x000b1;0.16 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">1.04&#x000b1;0.31 (7)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="middle" rowspan="2" align="left" colspan="1">Tibial nerve latency (m/s)</td><td valign="top" align="left" rowspan="1" colspan="1">Arthrodesis (12)</td><td valign="top" align="center" rowspan="1" colspan="1">5.02&#x000b1;1.87 (8)</td><td valign="top" align="center" rowspan="1" colspan="1">3.66&#x000b1;1.42 (12)</td><td valign="top" align="center" rowspan="1" colspan="1">3.51&#x000b1;0.76<xref ref-type="table-fn" rid="tfn3-medscimonit-21-2141">*</xref> (12)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total contact cast (9)</td><td valign="top" align="center" rowspan="1" colspan="1">4.61&#x000b1;1.10 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">4.74&#x000b1;1.12 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">5.87&#x000b1;1.43 (7)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="middle" rowspan="2" align="left" colspan="1">Tibial nerve conduction velocity (m/s)</td><td valign="top" align="left" rowspan="1" colspan="1">Arthrodesis (12)</td><td valign="top" align="center" rowspan="1" colspan="1">25.96&#x000b1;10.41 (8)</td><td valign="top" align="center" rowspan="1" colspan="1">42.32&#x000b1;15.74<xref ref-type="table-fn" rid="tfn3-medscimonit-21-2141">*</xref> (12)</td><td valign="top" align="center" rowspan="1" colspan="1">27.01&#x000b1;5.39 (12)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total contact cast (9)</td><td valign="top" align="center" rowspan="1" colspan="1">35.32&#x000b1;12.12 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">33.76&#x000b1;8.05 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">13.53&#x000b1;2.18<xref ref-type="table-fn" rid="tfn3-medscimonit-21-2141">*</xref> (7)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td valign="middle" rowspan="2" align="left" colspan="1">Peroneal nerve amplitude (&#x003bc;V)</td><td valign="top" align="left" rowspan="1" colspan="1">Arthrodesis (12)</td><td valign="top" align="center" rowspan="1" colspan="1">0.57&#x000b1;0.15 (8)</td><td valign="top" align="center" rowspan="1" colspan="1">2.07&#x000b1;0.57<xref ref-type="table-fn" rid="tfn3-medscimonit-21-2141">*</xref> (12)</td><td valign="top" align="center" rowspan="1" colspan="1">3.17&#x000b1;1.59<xref ref-type="table-fn" rid="tfn3-medscimonit-21-2141">*</xref> (12)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total contact cast (9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.51&#x000b1;0.15 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.53&#x000b1;0.90 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">0.33&#x000b1;0.52 (7)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="middle" rowspan="2" align="left" colspan="1">Peroneal nerve latency (m/s)</td><td valign="top" align="left" rowspan="1" colspan="1">Arthrodesis (12)</td><td valign="top" align="center" rowspan="1" colspan="1">10.69&#x000b1;2.50 (8)</td><td valign="top" align="center" rowspan="1" colspan="1">11.80&#x000b1;2.51 (12)</td><td valign="top" align="center" rowspan="1" colspan="1">9.40&#x000b1;3.71 (12)</td><td valign="top" align="center" rowspan="1" colspan="1">0.23</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total contact cast (9)</td><td valign="top" align="center" rowspan="1" colspan="1">9.50&#x000b1;2.44 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">9.49&#x000b1;0.98 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">12.53&#x000b1;4.11<xref ref-type="table-fn" rid="tfn3-medscimonit-21-2141">*</xref> (7)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td valign="middle" rowspan="2" align="left" colspan="1">Peroneal nerve conduction velocity (m/s)</td><td valign="top" align="left" rowspan="1" colspan="1">Arthrodesis (12)</td><td valign="top" align="center" rowspan="1" colspan="1">22.30&#x000b1;6.20 (8)</td><td valign="top" align="center" rowspan="1" colspan="1">33.30&#x000b1;14.81<xref ref-type="table-fn" rid="tfn3-medscimonit-21-2141">*</xref> (12)</td><td valign="top" align="center" rowspan="1" colspan="1">33.47&#x000b1;14.18<xref ref-type="table-fn" rid="tfn3-medscimonit-21-2141">*</xref> (12)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total contact cast (9)</td><td valign="top" align="center" rowspan="1" colspan="1">19.02&#x000b1;4.87 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">21.33&#x000b1;0.53 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">20.98&#x000b1;4.62 (7)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn3-medscimonit-21-2141"><label>*</label><p>P&#x0003c;0.05 <italic>vs.</italic> baseline.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t5-medscimonit-21-2141" position="float"><label>Table 5</label><caption><p>Quantitative sensory testing according to treatment.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="middle" align="center" rowspan="1" colspan="1">Variable</th><th valign="middle" align="center" rowspan="1" colspan="1">Group (total <italic>n</italic>)</th><th valign="middle" align="center" rowspan="1" colspan="1">Baseline (<italic>n</italic> of positive)</th><th valign="middle" align="center" rowspan="1" colspan="1">6 months (<italic>n</italic> of positive)</th><th valign="middle" align="center" rowspan="1" colspan="1">12 months (<italic>n</italic> of positive)</th><th valign="middle" align="center" rowspan="1" colspan="1">P-value for group-time interaction</th></tr></thead><tbody><tr><td valign="middle" rowspan="2" align="left" colspan="1">CPT (&#x000b0;C)</td><td valign="top" align="left" rowspan="1" colspan="1">Arthrodesis (12)</td><td valign="top" align="center" rowspan="1" colspan="1">22.51&#x000b1;1.13 (12)</td><td valign="top" align="center" rowspan="1" colspan="1">31.30&#x000b1;10.23<xref ref-type="table-fn" rid="tfn4-medscimonit-21-2141">*</xref> (12)</td><td valign="top" align="center" rowspan="1" colspan="1">26.82&#x000b1;1.10<xref ref-type="table-fn" rid="tfn4-medscimonit-21-2141">*</xref> (12)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total contact cast (9)</td><td valign="top" align="center" rowspan="1" colspan="1">22.35&#x000b1;0.80 (9)</td><td valign="top" align="center" rowspan="1" colspan="1">22.38&#x000b1;0.73 (9)</td><td valign="top" align="center" rowspan="1" colspan="1">22.54&#x000b1;1.59 (9)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="middle" rowspan="2" align="left" colspan="1">WPT (&#x000b0;C)</td><td valign="top" align="left" rowspan="1" colspan="1">Arthrodesis (12)</td><td valign="top" align="center" rowspan="1" colspan="1">45.69&#x000b1;0.78 (9)</td><td valign="top" align="center" rowspan="1" colspan="1">40.40&#x000b1;0.78<xref ref-type="table-fn" rid="tfn4-medscimonit-21-2141">*</xref> (12)</td><td valign="top" align="center" rowspan="1" colspan="1">41.02&#x000b1;1.03<xref ref-type="table-fn" rid="tfn4-medscimonit-21-2141">*</xref> (12)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total contact cast (9)</td><td valign="top" align="center" rowspan="1" colspan="1">45.52&#x000b1;0.80 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">44.54&#x000b1;1.17 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">45.80&#x000b1;5.32 (7)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="middle" rowspan="2" align="left" colspan="1">VPT (&#x003bc;m)</td><td valign="top" align="left" rowspan="1" colspan="1">Arthrodesis (12)</td><td valign="top" align="center" rowspan="1" colspan="1">5.98&#x000b1;0.92 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">3.72&#x000b1;0.67<xref ref-type="table-fn" rid="tfn4-medscimonit-21-2141">*</xref> (10)</td><td valign="top" align="center" rowspan="1" colspan="1">2.73&#x000b1;0.71<xref ref-type="table-fn" rid="tfn4-medscimonit-21-2141">*</xref> (10)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total contact cast (9)</td><td valign="top" align="center" rowspan="1" colspan="1">6.17&#x000b1;0.53 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">5.79&#x000b1;0.87 (7)</td><td valign="top" align="center" rowspan="1" colspan="1">5.88&#x000b1;0.53 (7)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="middle" rowspan="2" align="left" colspan="1">Pinprick</td><td valign="top" align="left" rowspan="1" colspan="1">Arthrodesis (12)</td><td valign="top" align="center" rowspan="1" colspan="1">(2)</td><td valign="top" align="center" rowspan="1" colspan="1">(7)</td><td valign="top" align="center" rowspan="1" colspan="1">(7)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total contact cast (9)</td><td valign="top" align="center" rowspan="1" colspan="1">(3)</td><td valign="top" align="center" rowspan="1" colspan="1">(3)</td><td valign="top" align="center" rowspan="1" colspan="1">(3)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="middle" rowspan="2" align="left" colspan="1">Light touch</td><td valign="top" align="left" rowspan="1" colspan="1">Arthrodesis (12)</td><td valign="top" align="center" rowspan="1" colspan="1">(2)</td><td valign="top" align="center" rowspan="1" colspan="1">(5)</td><td valign="top" align="center" rowspan="1" colspan="1">(5)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total contact cast (9)</td><td valign="top" align="center" rowspan="1" colspan="1">(3)</td><td valign="top" align="center" rowspan="1" colspan="1">(3)</td><td valign="top" align="center" rowspan="1" colspan="1">(3)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn4-medscimonit-21-2141"><label>*</label><p>P&#x0003c;0.05 <italic>vs.</italic> baseline; CPT &#x02013; cold perception threshold; WPT &#x02013; warm perception threshold; VPT &#x02013; vibration perception threshold.</p></fn></table-wrap-foot></table-wrap></floats-group></article>